Suppr超能文献

1型人类免疫缺陷病毒感染三联药物治疗后淋巴细胞动力学及CD4(+)CD45RA(+)CD62L(+)初始T细胞前体细胞频率依赖性恢复

Lymphocyte kinetics and precursor frequency-dependent recovery of CD4(+)CD45RA(+)CD62L(+) naive T cells following triple-drug therapy for HIV type 1 infection.

作者信息

Hengel R L, Jones B M, Kennedy M S, Hubbard M R, McDougal J S

机构信息

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30333, USA.

出版信息

AIDS Res Hum Retroviruses. 1999 Mar 20;15(5):435-43. doi: 10.1089/088922299311187.

Abstract

New therapeutic regimens have dramatically altered morbidity and mortality attributed to HIV-1 infection. Changes in lymphocyte subsets after treatment may mirror salutary clinical changes. Over 4 months we analyzed lymphocyte subsets in 20 patients starting new HIV-1 therapy. Absolute numbers of lymphocytes, CD4+ T cells, CD8+ T cells, and B cells increased significantly by 4 months, but CD8+ T cell and B cell increases were restricted to late-stage patients. Subset analysis revealed that the magnitude of recovering naive-phenotype CD4+ T cells (slope) correlated with the number of these cells present at baseline, equaling or exceeding the memory-phenotype slope within days if these naive cells were abundant at baseline. Five of 10 patients in whom naive-phenotype CD4+ T cells were absent at baseline partially repopulated these cells by 4 months. These findings have important implications for the origin and mechanisms of renewal of naive-phenotype CD4+ T cells following effective treatment for HIV-1 infection.

摘要

新的治疗方案已显著改变了由HIV-1感染所致的发病率和死亡率。治疗后淋巴细胞亚群的变化可能反映出有益的临床变化。在4个月的时间里,我们分析了20例开始接受新的HIV-1治疗的患者的淋巴细胞亚群。淋巴细胞、CD4+ T细胞、CD8+ T细胞和B细胞的绝对数量在4个月时显著增加,但CD8+ T细胞和B细胞的增加仅限于晚期患者。亚群分析显示,恢复的初始表型CD4+ T细胞数量的增加幅度(斜率)与基线时这些细胞的数量相关,如果基线时初始细胞数量丰富,则在数天内其增加幅度等于或超过记忆表型的斜率。10例基线时无初始表型CD4+ T细胞的患者中有5例在4个月时部分重新填充了这些细胞。这些发现对于HIV-1感染有效治疗后初始表型CD4+ T细胞的来源和更新机制具有重要意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验